MedTrace Logo

Comparative Study Between Alzheimer's and Multi-infarct Dementia

NCT05781139 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2023-03-23

No results posted yet for this study

Summary

Dementia is a neurological disease that causes cognitive and behavioral impairments that could ultimately interfere with the ability to function at work or to do the usual daily activities. It is recognized as a healthcare and social burden and remains challenging in terms of proper diagnosis and treatment.

Conditions

Interventions

DIAGNOSTIC_TEST

levels of Neurofilaments (NfL) in serum

the levels Neurofilaments (NfL) (Abcam, USA), C-X-C motif chemokine 13 (CXCL13) and Chitinase 3-like Protein 1 (Sigma-aldrich, Germany) will be determined in the serum and CSF (if available) in the different participant groups.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Eman M Khedr, professor · Assiut University

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-10
Primary Completion
2025-07-21
Completion
2026-02-21

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05781139 on ClinicalTrials.gov